Search

Your search keyword '"Coskun, H."' showing total 453 results

Search Constraints

Start Over You searched for: Author "Coskun, H." Remove constraint Author: "Coskun, H."
453 results on '"Coskun, H."'

Search Results

1. Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

4. Protective effect of magnesium preloading on cisplatin-induced nephrotoxicity: which dose is more suitable?

16. Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

33. Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study)

37. Prognosis of subglottic carcinoma: Is it really worse?

38. Prognosis of subglottic carcinoma: Is it really worse?

40. Lesions that mimic malignant tumors in nasopharyngeal biopsies: case series of 10 years

41. RELATIONSHIP BETWEEN CHANGES IN URIC ACID LEVELS AND WEIGHT LOSS AFTER BARIATRIC SURGERY

42. Selective neck dissection in surgically treated head and neck squamous cell carcinoma patients with a clinically positive neck: Systematic review

44. P1.14-15 Lorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkey

45. The effect of small-molecular-weight heparin added to chemotherapy on survival in small-cell lung cancer - A retrospective analysis

46. Can positron emission tomography-computed tomography predict response in locally advanced rectal cancer patients treated with induction folinic acid and 5-florouracil?

47. Selective neck dissection in surgically treated head and neck squamous cell carcinoma patients with a clinically positive neck: Systematic review

49. Monatshefte für Chemie - Chemical Monthly volume / Increase in electron scattering length in PEDOT:PSS by a triflic acid post-processing

50. P84.03 GLASS: Global Lorlatinib for ALK(+) and ROS1(+) Retrospective Study: Real World Data of 123 NSCLC Patients

Catalog

Books, media, physical & digital resources